Advertisement

Anaesthesia for Combined Cardiac and Thoracic Procedures

  • Marcin WąsowiczEmail author
Chapter

Abstract

Combined cardiac and thoracic procedures are rare; however thanks to progress of surgical techniques and recent advances in the use of extracorporeal life support (ECLS) techniques the number of these procedures is increasing.

Anaesthesia and optimal perioperative management for these complex, high-risk surgical interventions requires an expertise in both cardiac and pulmonary physiologies, lung isolation techniques, the multiorgan impact of cardiopulmonary bypass (CPB) and additional monitoring techniques (e.g. transesophageal echocardiography-TEE). Combined procedures may include excision of invasive tumours, pulmonary endarterectomy, cardiac revascularization combined with lung resection and cardiac procedures combined with lung transplantation (e.g. PFO closure). Optimal management of these procedures remains controversial and is not well described; in fact it is mainly limited to case reports (Marseu K et al. A A Case Rep 8:61–63, 2017; Slinger et al. Perioperative care in cardiac anaesthesia and surgery. Lippincott, Williams & Wilkins, Philadelphia/Baltimore/New York/London/Buenos Aires/Hong Kong/Sydney/Tokyo, 43–48, 2006). Proponents of single-stage operations will argue in favour of the avoidance of a second surgery and anaesthetic and reduced hospital stay (Slinger et al. Perioperative care in cardiac anesthesia and surgery. Lippincott, Williams & Wilkins, Philadelphia/Baltimore/New York/London/Buenos Aires/Hong Kong/Sydney/Tokyo, 43–48, 2006; Rao et al. Ann Thorac Surg 62:342-347, 1996). The opponents will argue for divided, two-stage procedures on the basis of limiting surgical trauma, blood loss, multiorgan impact of cardiopulmonary bypass and high intensive care morbidity and thus may potentially confer a better long-term survival (Rao et al. Ann Thorac Surg 62:342-347, 1996; Ciracio et al. Eur J Cardiothorac Surg 22:35–40, 2002).

The following chapter will briefly describe the anaesthetic management for various combined thoracic and cardiac procedures. For a better understanding of why CPB is detrimental for lung function, the author will briefly describe the structure and function of the air-blood barrier and pathophysiology of its injury during procedures with use of CPB.

Keywords

Cardiac anaesthesia Thoracic anaesthesia Combined cardiothoracic surgery 

Supplementary material

References

  1. 1.
    Marseu K, Minkovich L, Zubrinic M, Keshavjee S. Anesthetic considerations for pneumonectomy with left atrial resection on cardiopulmonary bypass in a patient with lung Cancer: a case report. A A Case Rep. 2017;8:61–3.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Slinger PD, Chang DCH, David TE, editors. Perioperative Care in Cardiac Anesthesia and Surgery. Philadelphia/Baltimore/New York/London/Buenos Aires/Homg Kong/Sydney/Tokyo: Lippincott, Williams&Wilkins; 2006. p. 43–8.Google Scholar
  3. 3.
    Rao V, Todd TRJ, Weisel RD, et al. Results of combined pulmonary resection and cardiac operation. Ann Thorac Surg. 1996;62:342–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Ciracio P, Carretta A, Calori G, Mazzone P, Zannini P. Lung resection for cancer in patients with coronary artery disease: analysis of short term results. Eur J Cardiothorac Surg. 2002;22:35–40.CrossRefGoogle Scholar
  5. 5.
    Wąsowicz M, Biczysko W, Marszałek A, Yokoyama S, Nakayama I. Ultrastructural studies on selected elements of the extra cellular matrix in the developing rat lung alveolus. Folia Histochem Cytobiol. 1998;36:3–13.PubMedGoogle Scholar
  6. 6.
    Wąsowicz M, Kashima K, Yokoyama S, Nakayama I. Pulmonary surfactant migrates into the alveolar capillaries of newborn rats an immunoelectron microscopic study. Acta Anat. 1996;156:11–21.CrossRefPubMedGoogle Scholar
  7. 7.
    Wąsowicz M. Biczysko W. In: Andres J, Wąsowicz M, editors. Selected problems of anesthesia and critical care in cardiovascular surgery. Kraków: Danbert; 2002. p. 174–89.Google Scholar
  8. 8.
    Wąsowicz M, Drwiła R, Biczysko W, Marszałek A, Florek E, Andres J. Effects of exogenous surfactant on alveolar barrier. An experimental study. Anaesth Inten Ther. 2002;34:76–80.Google Scholar
  9. 9.
    Wąsowicz M, Sobczyński P, Szulc R, Biczysko W. Ultrastructural changes in the lung alveoli after cardiac surgical operations with the use of cardiopulmonary bypass (CPB). Pol J Pathol. 1999;50:189–96.PubMedGoogle Scholar
  10. 10.
    Ng CSH, Wan S, Yim APC, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest. 2002;121:1269–77.CrossRefPubMedGoogle Scholar
  11. 11.
    Biczysko W, Wąsowicz M, Marszałek A. Stromal compartment in the developing lung’s alveoli- an electron microscopic study. Clin Perinat Gynaecol. 1994;6:107–19.Google Scholar
  12. 12.
    Wąsowicz M, Biczysko W, Sobczyński P. Structure and activity of pulmonary surfactant and their implications for intensive therapy. Inten Care Emerg Med. 1998;1:35–44.Google Scholar
  13. 13.
    Biczysko W, Wąsowicz M, Metzner J, Marszałek A. In: Drobnik L, Jurczyk W, editors. Problems of anesthesiology and intensive therapy. Warszawa: Wydawnictwo Lekarskie PZWL; 1998. p. 96–109.Google Scholar
  14. 14.
    Biczysko W, Marszałek A, Wąsowicz M. Maturation of lung epithelia in transmission electron microscopic study. Clin Perinat Gynaecol. 1993;3:3–23.Google Scholar
  15. 15.
    Doyle I, Nicholas TE, Bernste AD. Serum surfactant protein a levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152:307–17.CrossRefPubMedGoogle Scholar
  16. 16.
    Sobczyński P, Wąsowicz M. In: Zapalski S, Checinski P, editors. Clinical aspects of lung reperfusion. Clinical aspects of ischemia and reperfusion. Bielsko Biała: Alfa Medica Press; 1997. p. 79–89.Google Scholar
  17. 17.
    Wąsowicz M, Yokoyama S, Kashima K, Nakayama I. The connective tissue compartment in the terminal region of the developing rat lung. Acta Anat. 1996;156:268–82.CrossRefPubMedGoogle Scholar
  18. 18.
    Biczysko W, Wąsowicz M, Marszałek A, Florek E. Why do the lungs of premature newborns function improperly? A morphological study of the connective tissue and vascular compartments in the developing lung. Arch Perinat Med. 1999;5:19–26.Google Scholar
  19. 19.
    Danton MHD, Anikin VA, McManus KG, McGuigan JA, Campalani G. Simultaneous cardiac surgery with pulmonary resection: presentation of series and review of literature. Eur J Cardiothorac Surg. 1998;13:667–72.CrossRefPubMedGoogle Scholar
  20. 20.
    Wiebe K, Baraki H, Macchiarini M, Haverich A. Extended pulmonary resections of advanced thoracic malignancies with support of cardiopulmonary bypass. Eur J Cardiothorac Surg. 2006;29:571–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Dyszkiewicz W, Jemielity M, Piwkowski C, et al. The early and late results of combined off-pump coronary artery bypass grafting and pulmonary resection in patients with concomitant lung cancer and unstable coronary heart disease. Eur J Cardiothorac Surg. 2008;34:531–5.CrossRefPubMedGoogle Scholar
  22. 22.
    Spaggiari L, D’Aiuto M, Veronesi G, et al. Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass for lung cancer. Ann Thorac Surg. 2005;79:234–40.CrossRefPubMedGoogle Scholar
  23. 23.
    Voets AJ, Sheik Joesoef K, van Teeffelen MEJM. Synchronously occurring lung cancer (stages I-II) and coronary artery disease: concomitant versus staged surgical approach. Eur J Cardiothorac Surg. 1997;12:713–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Wąsowicz M. In: Andres J, Wąsowicz M, editors. Selected problems of anesthesia and critical care in cardiovascular surgery. Kraków: Danbert; 2002. p. 191–207.Google Scholar
  25. 25.
    Clark SC. Lung injury after cardiopulmonary bypass. Perfusion. 2006;21:225–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Sharma V, Rao V, Manlhiot C, Boruvka A, Fremes S, Wąsowicz M. A derived and validated score to predict prolonged mechanical ventilation in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2017;153:108–15.CrossRefPubMedGoogle Scholar
  27. 27.
    Weissman C. Pulmonary complications after cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004;8:185–211.CrossRefPubMedGoogle Scholar
  28. 28.
    Picone AL, Lutz CJ, Finck C, et al. Multiple sequential insults cause post-pump syndrome. Ann Thorac Surg. 1999;67:978–85.CrossRefPubMedGoogle Scholar
  29. 29.
    Tonz M, Milhajevic T, Von Segesser LK. Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible? Chest. 1995;198:1551–6.CrossRefGoogle Scholar
  30. 30.
    Wąsowicz M, Drwiła R, Sobczyński P, Przybyłowski P, Dziatkowiak A. Lung alveolar damage during coronary artery bypass grafting with use of cardiopulmonary-bypass: and old nemesis? Br J Anaesth. 2000;84(supp 1):18.Google Scholar
  31. 31.
    Wąsowicz M, Sobczyński P, Drwiła R, Biczysko W, Marszałek A, Andres J. Air-blood barrier injury during cardiac operations with the use of cardiopulmonary bypass (CPB). An old story? Scand Cardiovasc J. 2003;37:216–21.CrossRefPubMedGoogle Scholar
  32. 32.
    Kotani N, Hashimoto H, Sessler DI, et al. Neutrophil number and interleukin-8 and elastase concentration in bronchoalveolar lavage fluid correlate with decreased arterial oxygenation after cardiopulmonary bypass. Anesth Analg. 2000;90:1046–51.CrossRefPubMedGoogle Scholar
  33. 33.
    Kotani N, Hashimoto H, Sessler DI, et al. Cardiopulmonary bypass produces greater pulmonary than systemic proinflammatory cytokines. Anesth Analg. 2000;90:1039–45.CrossRefPubMedGoogle Scholar
  34. 34.
    Sinclair DG, Haslam PL, Quinlan GL, Pepper JR, Evans TW. The effects of cardiopulmonary bypass on interstitial and pulmonary endothelial permeability. Chest. 1995;108:718–24.CrossRefPubMedGoogle Scholar
  35. 35.
    Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anesth. 1993;40:1016–21.CrossRefPubMedGoogle Scholar
  36. 36.
    Chenoweth DE, Cooper SW, Hugli TE, et al. Complement activation during cardiopulmonary bypass. Evidence for generation C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497–503.CrossRefPubMedGoogle Scholar
  37. 37.
    Warner AE. Pulmonary intravascular macrophages. Role in acute lung injury. Clin Cest Med. 1996;17:125–35.CrossRefGoogle Scholar
  38. 38.
    Royston D, Fleming JS, Desai JB, et al. Increased production of peroxidation products associated with cardiac operations. Evidence for free radical generation. J Thorac Cardiovasc Surg. 1986;91:75–766.Google Scholar
  39. 39.
    Wąsowicz M, Drwiła R, Jeleń H, Przybyłowski P, Andres J, Dziatkowiak A. Lipid peroxidation (LO) during cardiac operations with use of cardiopulmonary bypass measured by headspace chromatography. Eur J Anaesthesiol. 2001;18(supp. 22):19.CrossRefGoogle Scholar
  40. 40.
    Wąsowicz M, Drwiła R, Jeleń H, Przybyłowski P, Andres J, Dziatkowiak A. Lipid peroxidation (LO) during cardiac operations with use of cardiopulmonary bypass measured by headspace chromatography. Eur J Anaesthesiol. 2001;18(supp. 22):19.CrossRefGoogle Scholar
  41. 41.
    Rady MY, Ryan T, Star NY. Early onset of acute pulmonary dysfunction after cardiovascular surgery; risk factors and clinical outcomes. Crit Care Med. 1997;25:1831–9.CrossRefPubMedGoogle Scholar
  42. 42.
    Magnusson L, Zemgulis V, Wicky ZS, Tyden H, Thelin S, et al. Atelectasis is a major cause of hypoxemia and shunt after cardiopulmonary bypass. Anethesiology. 1997;87:1153–63.CrossRefGoogle Scholar
  43. 43.
    Bouza E, Perez A, Munoz P, et al. Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med. 2003;31:1964–70.CrossRefPubMedGoogle Scholar
  44. 44.
    Gaynes R, Bizek B, Movry-Hanley J, et al. Risk factors for nosocomial pneumonia after coronary artery bypass operations. Ann Thorac Surg. 1991;51:215–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion. 2004;44:1453–62.CrossRefPubMedGoogle Scholar
  46. 46.
    Taggard DP. Respiratory dysfunction after cardiac surgery: effect of avoiding cardiopulmonary bypass and the use of bilateral internal mammary artery. Eur J Cardiovasc Surg. 2000;18:31–7.CrossRefGoogle Scholar
  47. 47.
    Richter JA, Meisner H, Tassani P, et al. Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting. Ann Thorac Surg. 2000;69:7783.CrossRefGoogle Scholar
  48. 48.
    Minkovich L, Djaiani G, Katznelson R, et al. Effects of alveolar recruitment on arterial oxygenation in patients after cardiac surgery: a prospective, randomized, controlled clinical trial. J Cardiothorac Vasc Anesth. 2007;21:375–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Tassani P, Richter P, Barankay A, et al. Does high-dose methylprednisolone in aprotinin-treated patients attenuates the systemic inflammatory response during coronary artery bypass grafting procedures? J Cardiothorac Vasc Anesth. 1999;13:165–72.CrossRefPubMedGoogle Scholar
  50. 50.
    Saxena P, Tam RKW. Combined off-pump coronary artery bypass surgery and pulmonary resection. Ann Thorac Surg. 2004;78:498–501.CrossRefPubMedGoogle Scholar
  51. 51.
    Ng CSH, Arifi AA, Wan S, Wai S, Lee TW, Yim APC. Cardiac operation with associated pulmonary resection: a word of caution. Asian Cardiovasc Thorac J. 2002;10:362–4.CrossRefGoogle Scholar
  52. 52.
    Klepetko W. Surgical intervention for T4 lung cancer with infiltration of the thoracic aorta: are we back to the archetype of surgical thinking? J Thorac Cardiovasc Surg. 2005;129:727–9.CrossRefPubMedGoogle Scholar
  53. 53.
    De Perrot M, Fadel ZE, Mussot S, de Palma A, Chapelier A, Dartevelle P. Resection of locally advanced (T4) non-small cell lung cancer with cardiopulmonary bypass. Ann Thorac Surg. 2005;79:1691–7.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Dyszkiewicz W, Jemielity MM, Piwkowski CT, Perek B, Kasprzyk M. Simultaneous lung resection for cancer and myocardial revascularization without cardiopulmonary bypass (off-pump coronary artery bypass grafting). Ann Thorac Surg. 2004;77:1023–7.CrossRefPubMedGoogle Scholar
  55. 55.
    Mariani M, vn Boven W, Duurkens VAM, et al. Combined off-pump coronary surgery and right lung resections through midline sternotomy. Ann Thorac Surg. 2001;71:1342–4.CrossRefGoogle Scholar
  56. 56.
    Marcucci C, Chassot P-G, Gardaz J-P, Magnusson L, et al. Fatal myocardial infarction after lung resection in a patient with prophylactic preoperative coronary stenting. Br J Anaesth. 2004;92:743–7.CrossRefPubMedGoogle Scholar
  57. 57.
    Shudo Y, Takahashi T, Ohta M, et al. Radical operation for invasive thymoma with intracaval, intracardiac and lung invasion. J Card Surg. 2007;22:330–2.CrossRefPubMedGoogle Scholar
  58. 58.
    Nakajima J, Morota T, Matsumoto J, et al. Pulmonary intimal sarcoma treated by a left pneumonectomy with pulmonary arterioplasty under cardiopulmonary bypass: report of case. Surg Today. 2007;37:496–9.CrossRefPubMedGoogle Scholar
  59. 59.
    Venuta F, Ciccone AM, Anile M, et al. Reconstruction of the pulmonary artery for lung cancer: long-term results. J Thorac Cardiovasc Surg. 2009;138:1185–91.CrossRefPubMedGoogle Scholar
  60. 60.
    Ratto GB, Costa R, Vassallo G, et al. Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer. Ann Thorac Surg. 2004;78:234–7.CrossRefPubMedGoogle Scholar
  61. 61.
    Francesca L, Frazier OH, Radovancevic B, De Caro LF, Reul GJ, Cooley DA. Concomitant cardiac and pulmonary operations for lung cancer. Tex Heart Inst J. 1995;22:296–300.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Lennon PF, Hartigan PM, Friedberg JS. Clinical management of patients undergoing concurrent cardiac surgery and pulmonary resection. J Cardiothorac Vac Anesth. 1998;12:587–90.CrossRefGoogle Scholar
  63. 63.
    Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, Butterworth J. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology. 2002;97(2):390–9.CrossRefPubMedGoogle Scholar
  64. 64.
    Sharma V, Fan J, Jerath A, Pang KS, Bojko B, Pawliszyn J, Karski JM, Yau T, McCluskey S, Wąsowicz M. Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass. Anaesthesia. 2012 Nov 1;67(11):1242–50.CrossRefPubMedGoogle Scholar
  65. 65.
    Jearth A, Yang JQ, Pang KS, Lobby N, Vasicic T, Reyes N, Bojko B, PAwliszyn J, Wijeysundera D, Beattie WS, Wąsowicz M. Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction: a new dosing regimen. Anesth Analg. 2018.; published ahead of printGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Anesthesia and Pain ManagementToronto General Hospital, University Health Network and Department of Anesthesia University of TorontoTorontoCanada
  2. 2.Cardiovascular Intensive Care UnitToronto General HospitalTorontoCanada

Personalised recommendations